Erratum in: Assessment of Neuroprotective Effects of Glutamate Modulation on Glaucoma-Related Retinal Ganglion Cell Apoptosis In Vivo
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNeurological Disorders and Treatments · Neuroscience and Neuropharmacology Research · Neurological Disease Mechanisms and Treatments
Erratum in: “Assessment of Neuroprotective Effects of Glutamate Modulation on Glaucoma-Related Retinal Ganglion Cell Apoptosis In Vivo” by Li Guo, Thomas E. Salt, Annelie Maass, Vy Luong, Stephen E. Moss, Fred W. Fitzke, and M. Francesca Cordeiro (Invest Ophthalmol Vis Sci. 2006;47(2):626-633), https://doi.org/10.1167/iovs.05-0754.
It has come to the authors' attention that the original caption for Figure 2C was incorrect. It used the term SSP as opposed to an OHT (IOP-elevated) model. It also failed to cite the original source of the image. The caption has now been corrected in the article online as follows:
Figure 2. Histologic confirmation that apoptotic cells (A, labeled with Annexin V/Alexa-488, white) were localized to RGCs (B, retrograde labeled with DiAsp4, gray), as shown in the combined micrograph (C), in an OHT model. C is reproduced in part from figure 1B in Ref. 2.